Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Current pharmaceutical options help many patients, but the search for more effective treatments continues
Ann Rheum Dis (2021) 80(2):1628
.jpg)
Retatrutide: Complication Focus TRIUMPH-4: Obesity + knee osteoarthritis (445 participants) TRIUMPH-2: Obesity + type 2 diabetes TRIUMPH-6: Weight maintenance trial Advantage: Multiple complication-specific trials could lead to broader label (obesity + OA + OSA indications)
Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs Image content: This image is available to view online
an increase in the placebo group.117 Results from the PIONEER program demonstrate that oral semaglutide is effective, safe, and well tolerated for glycemic control in patients with DM2, including those with DKD, with the specific benefits of this family of drugs
